Asahi Life Asset Management CO. LTD. Takes Position in CME Group Inc. (NASDAQ:CME)

Asahi Life Asset Management CO. LTD. bought a new position in CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 500 shares of the financial services provider’s stock, valued at approximately $106,000.

Other large investors also recently bought and sold shares of the company. Certified Advisory Corp bought a new position in shares of CME Group during the 1st quarter valued at $27,000. Solstein Capital LLC purchased a new position in CME Group in the first quarter worth about $28,000. RE Advisers Corp bought a new stake in shares of CME Group during the 2nd quarter valued at about $38,000. Capital Analysts LLC increased its position in shares of CME Group by 370.0% during the 1st quarter. Capital Analysts LLC now owns 188 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 148 shares during the last quarter. Finally, Glassman Wealth Services lifted its stake in shares of CME Group by 54.0% in the 2nd quarter. Glassman Wealth Services now owns 191 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 67 shares during the period. 86.19% of the stock is owned by institutional investors and hedge funds.

NASDAQ CME opened at $188.85 on Wednesday. CME Group Inc. has a 12 month low of $146.89 and a 12 month high of $221.82. The stock has a market cap of $67.82 billion, a price-to-earnings ratio of 35.30 and a beta of 0.43. The company’s 50 day moving average is $204.38 and its two-hundred day moving average is $208.14. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.59 by $0.05. CME Group had a net margin of 41.64% and a return on equity of 8.33%. The business had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.17 billion. Sell-side analysts forecast that CME Group Inc. will post 6.65 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 27th. Shareholders of record on Friday, September 10th will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date is Thursday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 53.57%.

Several equities analysts have recently weighed in on CME shares. Berenberg Bank reiterated a “hold” rating on shares of CME Group in a research note on Wednesday. Atlantic Securities upgraded shares of CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price objective on the stock in a research note on Tuesday. TheStreet cut shares of CME Group from a “b” rating to a “c+” rating in a research note on Wednesday, August 18th. Finally, Morgan Stanley increased their price objective on shares of CME Group from $228.00 to $229.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 1st. One analyst has rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, CME Group currently has a consensus rating of “Hold” and an average price target of $210.83.

In related news, Director Martin J. Gepsman sold 1,000 shares of the firm’s stock in a transaction on Monday, August 23rd. The shares were sold at an average price of $201.37, for a total value of $201,370.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sean Tully sold 5,000 shares of the firm’s stock in a transaction on Tuesday, August 24th. The shares were sold at an average price of $200.20, for a total transaction of $1,001,000.00. Following the completion of the transaction, the insider now directly owns 23,479 shares of the company’s stock, valued at $4,700,495.80. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 9,000 shares of company stock valued at $1,786,150. Insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

See Also: Conference Calls

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.